Copyright © 2024 - Designed & Maintained By Nusite IT Management Consultants
Revna Biosciences receives historic Food and Drugs Authority (FDA) approval for NeuMoDx™ 96 from QIAGEN, the first in Sub-Saharan Africa
The FDA approval secures RevnaBio as the first biomedical company to register/deploy the NeuMoDx platform in Sub-Saharan Africa, hitherto mainly available in Europe, the Middle East, and North America Ghana-based precision medicine company Revna Biosciences (RevnaBio) () has received historic…